Skip to main content
TipRanks
Go Ultimate75% OFF

Compare MARR S.p.A. (M6Z) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:M6ZMARR S.p.A.EUR 4.58EUR 320.98M17.02-43.94%HoldUnlock the DE:M6Z analyst price target with TipRanks PremiumDE:M6ZUnlock the DE:M6Z top-analyst price target with TipRanks Premium
IT:CPRDavide Campari-Milano SpAEUR 6.52EUR 11.78B28.3621.59%Strong BuyUnlock the IT:CPR analyst price target with TipRanks PremiumDE:M6Z vs IT:CPRUnlock the IT:CPR top-analyst price target with TipRanks Premium
IT:ORSOrsero SpAEUR 14.16EUR 249.74M10.02-17.00%Moderate BuyUnlock the IT:ORS analyst price target with TipRanks PremiumDE:M6Z vs IT:ORSUnlock the IT:ORS top-analyst price target with TipRanks Premium
IT:FFFine Foods & Pharmaceuticals N.T.M. SpAEUR 5.10EUR 131.01M-40.83-43.58%Moderate BuyUnlock the IT:FF analyst price target with TipRanks PremiumDE:M6Z vs IT:FFUnlock the IT:FF top-analyst price target with TipRanks Premium
IT:IWBItalian Wine Brands S.p.A.EUR 15.50EUR 148.05M10.52-28.24%Moderate BuyUnlock the IT:IWB analyst price target with TipRanks PremiumDE:M6Z vs IT:IWBUnlock the IT:IWB top-analyst price target with TipRanks Premium
IT:NWLNewPrinces S.p.A.EUR 25.22EUR 1.09B4.2246.63%Moderate BuyUnlock the IT:NWL analyst price target with TipRanks PremiumDE:M6Z vs IT:NWLUnlock the IT:NWL top-analyst price target with TipRanks Premium

Performance Comparison

-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:M6ZMARR S.p.A.4.58-3.51-43.39%
IT:CPRDavide Campari-Milano SpA6.521.0819.80%
IT:ORSOrsero SpA14.16-2.27-13.83%
IT:FFFine Foods & Pharmaceuticals N.T.M. SpA5.10-3.83-42.86%
IT:IWBItalian Wine Brands S.p.A.15.50-5.75-27.07%
IT:NWLNewPrinces S.p.A.25.228.3249.23%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts